Constipation News and Research

Latest Constipation News and Research

Schizophrenia drug to be used to treat autism

A drug normally used to treat schizophrenia has been given approval by the U.S. the Food and Drug Administration for use in treating the symptoms of autism in children and adolescents.

9 Oct 2006

Canadians paralysed after drinking carrot juice

Carrot juice which was withdrawn from the market late last month is thought to be responsible for the illness of two Canadians who are paralyzed and are severely ill in hospital.

9 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

FDA approves Risperdal to treat irritability associated with autism

The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.

8 Oct 2006

Study compares delivery methods of schizophrenia medicines

More than half of schizophrenia patients don't take their medication as directed and a new study will determine whether biweekly physician visits and injectable drugs can change that.

12 Sep 2006

Male sufferers now have access to osteoporosis drug Actonel

The U.S. Food and Drug Administration (FDA) has given it's approval for the drug Actonel (risedronate sodium) to be used to treat osteoporosis in men.

15 Aug 2006

Drugs for preventing postoperative nausea and vomiting

Patients coming out of anesthesia after surgery may experience nausea or vomiting, and are frequently given drugs to prevent this. But the majority of patients won't benefit from these drugs, according to a large new review of studies.

19 Jul 2006

New drug will treat those winter blues

The U.S. Food and Drug Administration (FDA) has given it's approval for a drug to treat a condition known as Seasonal Affective Disorder (SAD).

14 Jun 2006

Hydrophobic statins not associated with increased breast cancer risk

A report published in the Journal of the National Cancer Institute found that women who took statins--the widely used cholesterol lowering drugs--do not face an increased breast cancer risk as had been suggested by some previous studies.

6 Jun 2006

Cognitive behavioral therapy effective in treating irritable bowel syndrome

According to the latest research behavioral therapy was more effective in treating the symptoms of irritable bowel syndrome (IBS) than being on a waiting list for treatment.

29 May 2006

Total versus subtotal hysterectomy for benign gynaecological conditions

Women who undergo a total hysterectomy, in which both the uterus and the cervix are removed, are no more likely to experience sexual difficulties or urinary or bowel problems after surgery than women who have only their uterus removed, a new review has found.

23 May 2006

New drug may revolutionize how chronic iron overload is treated in chronic anemia patients

Those with severe chronic anemias need frequent blood transfusions to remain healthy, but such frequent transfusions can cause a potentially deadly buildup of iron in the body, leading to heart and liver failure. The traditional treatment to remove excess iron is so onerous that many patients choose to forgo it, putting their own lives at risk. The results of an international study on deferasirox, a new drug that may revolutionize the way chronic iron overload is treated, will be published in the May 1, 2006, issue of Blood, the official journal of the American Society of Hematology.

26 Apr 2006

First study of uterine fibroid embolization to treat post-menopausal women

The first study of uterine fibroid embolization to treat post-menopausal women shows that the non-surgical treatment was technically successful in 100 percent of patients, and improved bulk-related symptoms in 92 percent of the women.

4 Apr 2006

Rifaximin effective in treating flatulence and irritable bowel syndrome

In the first study of its kind, researchers discovered that rifaximin, an antibiotic used to treat diarrhea, is an effective treatment for abdominal bloating and flatulence, including in irritable bowel syndrome (IBS) patients.

16 Feb 2006

Watchful waiting may be appropriate for some inguinal hernia patients

As long as they remain under the watchful eyes of their primary care physicians, men who have an inguinal hernia (a weakening of the abdominal wall that bulges into the groin area) may postpone surgical repair unless the condition causes symptoms that interfere with their usual activities.

23 Jan 2006

rhTSH combined with radiation therapy successfully destroys remaining thyroid tissue

A multicenter international study, including Johns Hopkins, has found that after surgery for thyroid cancer, giving genetically engineered human thyroid-stimulating hormone (rhTSH) before radioiodine treatment avoids the previous need to stop thyroid replacement therapy and the miserable side effects that go with it.

9 Jan 2006

Modified version of Atkins diet effective at controlling childhood seizures

A modified version of a popular low-carbohydrate, high-fat diet is nearly as effective at controlling seizures as the highly restrictive ketogenic diet, Johns Hopkins Children's Center researchers report.

7 Dec 2005

Treating Irritable Bowel Syndrome with constipation may have a significant impact on absenteeism

"IBS symptoms of abdominal pain or discomfort, bloating and constipation are associated with impaired quality of life and are the second most common cause of work-related absenteeism," according to Dr. Nigel Flook of the University of Alberta.

1 Nov 2005

Researchers find gene that is important for the control of fundamental rhythms in nematode worms

University of Utah biologists found a gene that controls rhythmic events in a worm's life: swallowing food, laying eggs and pooping.

9 Oct 2005

Physical activity may reduce gastrointestinal symptoms in people who are obese

In a study published in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, researchers found that a high body mass index (BMI) and lack of physical activity were associated with an increase in GI symptoms such as stomach pain, diarrhea, constipation and irritable bowel syndrome (IBS).

3 Oct 2005